Phosphatidylinositol 3,5-bisphosphate: Low abundance, high significance
Recent studies of the low abundant signaling lipid, phosphatidylinositol 3,5‐bisphosphate (PI(3,5)P2), reveal an intriguingly diverse list of downstream pathways, the intertwined relationship between PI(3,5)P2 and PI5P, as well as links to neurodegenerative diseases. Derived from the structural lipi...
Saved in:
Published in: | BioEssays Vol. 36; no. 1; pp. 52 - 64 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Blackwell Publishing Ltd
01-01-2014
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Recent studies of the low abundant signaling lipid, phosphatidylinositol 3,5‐bisphosphate (PI(3,5)P2), reveal an intriguingly diverse list of downstream pathways, the intertwined relationship between PI(3,5)P2 and PI5P, as well as links to neurodegenerative diseases. Derived from the structural lipid phosphatidylinositol, PI(3,5)P2 is dynamically generated on multiple cellular compartments where interactions with an increasing list of effectors regulate many cellular pathways. A complex of proteins that includes Fab1/PIKfyve, Vac14, and Fig4/Sac3 mediates the biosynthesis of PI(3,5)P2, and mutations that disrupt complex function and/or formation cause profound consequences in cells. Surprisingly, mutations in this pathway are linked with neurological diseases, including Charcot‐Marie‐Tooth syndrome and amyotrophic lateral sclerosis. Future studies of PI(3,5)P2 and PI5P are likely to expand the roles of these lipids in regulation of cellular functions, as well as provide new approaches for treatment of some neurological diseases.
Phosphatidylinositol 3,5‐bisphosphate (PI(3,5)P2), a low abundance phospholipid, regulates many cellular pathways. A protein complex that includes Fab1/PIKfyve, Vac14, and Fig4/Sac3 synthesizes PI(3,5)P2. Mutations in the Fab1/PIKfyve complex have profound effects in all organisms tested, and result in human diseases including Charcot‐Marie‐Tooth syndrome and amyotrophic lateral sclerosis. |
---|---|
Bibliography: | istex:465FCD3173DC18513C0ABA59FCC62BB0AF2E8659 ArticleID:BIES201300012 ark:/67375/WNG-553Z4P3B-R NRSA F31NS074740 and Rackham Predoctoral Fellowship ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors have contributed equally to this work. |
ISSN: | 0265-9247 1521-1878 |
DOI: | 10.1002/bies.201300012 |